2-chloro-5-methyl-1,3,4-thiadiazole, 95.0%, 100mg

3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1-[tris(1-methylethyl)silyl]-1H-pyrrole, 95.0%, 5g

3-Cyclopentylisoxazole-4-carboxylic acid, 95%, 250mg

Indio en polvo, mínimo 99 %, pa, 5 g, envase de vidrio

3-(tert-Butyl) 4-methyl (2S,4R)-2-(tert-butyl)oxazolidine-3,4-dicarboxylate, 98%, 1g

Methyl 5-amino-2-chloronicotinate, 95.0%, 1g

(2-Chloro-4-fluoropyridin-3-yl)methanol, 98%, 500mg

(E)-5-Methylhex-3-enoic acid, 98.0%, 250mg

Di-tert-butyl 1-cyclopropylhydrazine-1,2-dicarboxylate, 97%, 100mg

(1S,5R)-9-methyl-3,9-diazabicyclo[3.3.2]decan-10-one dihydrochloride, 95.0%, 250mg

N-Methyl-N-(methylsulfonyl)glycine, 95.0%, 100mg

4-(4-Butylphenylazo)phenol, 98%, 1g

3-Amino-N-tert-butyl-benzenesulfonamide, 95.0%, 100mg